sarilumab (kevzara) Report issue

Biologics mAb Approved FDA
AACT ChEMBL DrugBank Drugs@FDA
Back

Drug Pricing Summary

VA Big4

$982.0200 - $2438.0100

VA FSS

$982.0200 - $3199.8300

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
sarilumab 150 mg / 1.14 mL (1.1 mL INJECTION) $982.0200 VA Big4
  • KEVZARA (2)
    		•  Sanofi Aventis U.S. LLC
    sarilumab 150 mg / 1.14 mL (1.1 mL INJECTION) $982.0200 VA FSS
  • KEVZARA (2)
    		•  Sanofi Aventis U.S. LLC
    sarilumab 150 mg / 1.14 mL (1.1 mL INJECTION) $2438.0100 VA Big4
  • KEVZARA (1)
    		•  Sanofi Aventis U.S. LLC
    sarilumab 150 mg / 1.14 mL (1.1 mL INJECTION) $3199.8300 VA FSS
  • KEVZARA (1)
    		•  Sanofi Aventis U.S. LLC
    sarilumab 200 mg / 1.14 mL (1.1 mL INJECTION) $982.0200 VA Big4
  • KEVZARA (2)
    		•  Sanofi Aventis U.S. LLC
    sarilumab 200 mg / 1.14 mL (1.1 mL INJECTION) $982.0200 VA FSS
  • KEVZARA (2)
    		•  Sanofi Aventis U.S. LLC
    sarilumab 200 mg / 1.14 mL (1.1 mL INJECTION) $2425.4500 VA Big4
  • KEVZARA (1)
    		•  Sanofi Aventis U.S. LLC
    sarilumab 200 mg / 1.14 mL (1.1 mL INJECTION) $3199.8300 VA FSS
  • KEVZARA (1)
    		•  Sanofi Aventis U.S. LLC

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue